1. Update of FIP to IPC meeting Luc Besançon FIP General Secretary & CEO

2. FIP membership: 132 Member Organisations and 19 Observer organisations 2 + 4000 individuals gathered in 8 (practice) sections and 8 (sciences) special interest groups + 124 schools of pharmacy

3. Updates of FIP activities Ebola: tools for pharmacy workforce: www.fip.org/ebola www.fip.org/ebola –EVD: Information and Guidelines for Pharmacists and the Pharmacy Workforce –Quick guidance/poster: EVD – –What can pharmacists do about it? –Disease transmission and control –Patient screening and referral –EVD – Infection control –PowerPoint presentation of the guidelines: EVD – What can pharmacists do about it? 3

4. Updates of FIP activities Remuneration of community and hospital pharmacy activities: –50 countries covered –Case studies now under development –Report to be released by September 2015, linking this remuneration with UHC 4 Type of remuneration Product-based includes: Margin on a product, Add-on a product, Add-on a prescription… Fee for services Others including all combination possible!

5. Updates of FIP activities Publications released at the last FIP Congress (in Bangkok): –Statement on the code of Ethics for pharmacists –Model oath for pharmacists –FIP Education initiative: –Report on CPD/CE for pharmaceutical workforce –Framework for Quality Assurance for pharmacy education –FIP UNESCO-UNITWIN Centre of Excellence for Africa Draft report on environment and pharmaceuticals – submitted for comments Campaign on SSFFC in India (finalised by March 2015) on behalf of the World Health Professions Alliances Launch of the DOT pharmacy a month ago with NABP. New President of FIP: Dr Carmen Peña (Spain): 2014-2018 5

6. Coming up in 2015 and 2016 FIP Education Initiative: Reports on workforce trends, Report on interprofessional education a Report on advanced practice / specialisation Work on medicines shortages will continue in collaboration with WHO. Global Conference on Pharmacy and Pharmaceutical Sciences Education (2016: held in China) Statement on harm reduction and addiction 6